ABSTRACT
Objective To investigate the clinical efficacy of cupping treatment for recurrent mycotic vaginitis. Method Three hundred and eighty-three patients with recurrent mycotic vaginitis were randomly allocated, including 188 cases to a control group and 195 cases to an observation group. The control group received vaginal administration of clotrimazole and oral administration of sporanox and the observation group, cupping treatment in addition. Re-examination was made after two weeks of treatment. The clinical therapeutic effects and the clinical scores were compared between the two groups. Result In the observation group, clinical cure occurred in 96 patients, accounting for 49.2%; marked effectiveness, in 45 patients, accounting for 23.1%; effectiveness, in 34 patients, accounting for 17.4%; ineffectiveness, in 20 patients, accounting for 10.3%, with a total efficacy rate of 89.7%. In the control group, clinical cure occurred in 78 patients, accounting for 41.5%; marked effectiveness, in 34 patients, accounting for 18.1%; effectiveness, in 33 patients, accounting for 17.6%; ineffectiveness, in 43 patients, accounting for 22.9%, with a total efficacy rate of 77.1%.The clinical therapeutic effect was significantly better in the observation group than in the control group (P<0.05). There was a statistically significant pre-/post-treatment difference in the clinical score in the two groups (P<0.05) and a statistically significant post-treatment difference in the clinical score between the two groups (P<0.05).Conclusion Cupping can improve the clinical therapeutic effect on recurrent mycotic vaginitis and relieve its clinical symptoms.
ABSTRACT
Objective To observe the therapeutic efficacy of balance cupping plusYang He decoction in treating granulomatous mastitis (GM).Method Eighty GM patients were randomized into a treatment group and a control group according to the last digit of registered number, odd or even, 40 cases each. The control group was treated withYang He decoction; the treatment group was intervened by balance cupping in addition to the treatment given to the control group. They were treated for 6 months in total. The size of lump, swollen size and infection size by the ultrasound B-scanning were observed before and after the treatment, and the clinical efficacies were compared between the two groups.Result The total effective rate was 82.5％ in the treatment group versus 60.0％ in the control group, and the between-group difference was statistically significant (P<0.05). There was a significant difference in comparing the clinical efficacy between the two groups (P<0.05). The size of lump, swollen area and infection size by the ultrasound B-scanning were significantly changed in the two groups after the treatment (P<0.05); the between-group comparisons showed significant differences after the treatment (P<0.05).Conclusion Balance cupping plusYang He decoction can produce a certain efficacy in treating GM.
ABSTRACT
Objective To investigate the clinical efficacy of cupping treatment for recurrent mycotic vaginitis. Method Three hundred and eighty-three patients with recurrent mycotic vaginitis were randomly allocated, including 188 cases to a control group and 195 cases to an observation group. The control group received vaginal administration of clotrimazole and oral administration of sporanox and the observation group, cupping treatment in addition. Re-examination was made after two weeks of treatment. The clinical therapeutic effects and the clinical scores were compared between the two groups. Result In the observation group, clinical cure occurred in 96 patients, accounting for 49.2%; marked effectiveness, in 45 patients, accounting for 23.1%; effectiveness, in 34 patients, accounting for 17.4%; ineffectiveness, in 20 patients, accounting for 10.3%, with a total efficacy rate of 89.7%. In the control group, clinical cure occurred in 78 patients, accounting for 41.5%; marked effectiveness, in 34 patients, accounting for 18.1%; effectiveness, in 33 patients, accounting for 17.6%; ineffectiveness, in 43 patients, accounting for 22.9%, with a total efficacy rate of 77.1%.The clinical therapeutic effect was significantly better in the observation group than in the control group (P<0.05). There was a statistically significant pre-/post-treatment difference in the clinical score in the two groups (P<0.05) and a statistically significant post-treatment difference in the clinical score between the two groups (P<0.05).Conclusion Cupping can improve the clinical therapeutic effect on recurrent mycotic vaginitis and relieve its clinical symptoms.
ABSTRACT
Objective To observe the therapeutic efficacy of balance cupping plusYang He decoction in treating granulomatous mastitis (GM).Method Eighty GM patients were randomized into a treatment group and a control group according to the last digit of registered number, odd or even, 40 cases each. The control group was treated withYang He decoction; the treatment group was intervened by balance cupping in addition to the treatment given to the control group. They were treated for 6 months in total. The size of lump, swollen size and infection size by the ultrasound B-scanning were observed before and after the treatment, and the clinical efficacies were compared between the two groups.Result The total effective rate was 82.5％ in the treatment group versus 60.0％ in the control group, and the between-group difference was statistically significant (P<0.05). There was a significant difference in comparing the clinical efficacy between the two groups (P<0.05). The size of lump, swollen area and infection size by the ultrasound B-scanning were significantly changed in the two groups after the treatment (P<0.05); the between-group comparisons showed significant differences after the treatment (P<0.05).Conclusion Balance cupping plusYang He decoction can produce a certain efficacy in treating GM.
ABSTRACT
This study was aimed to investigate the effect of Honokiol (HNK) on proliferation and apoptosis of acute myeloid leukemia HL-60 cells and its potential mechanism. Inhibitory effect of HNK on the HL-60 cell proliferation was detected by MTT assay. Flow cytometry was used to detect the change of cell cycle and AnnexinV/PI staining was used to detect apoptosis. Western blot was applied to analyze the cell cycle protein (cyclins), cyclin-dependent kinase (CDK), P53, P21, P27, BCL-2, BCL-XL, Bax, caspase-3/9 and proteins for MAPK signal pathway. The results showed that HNK could inhibit the proliferation of HL-60 cells in time- and dose dependent ways. HNK arrested HL-60 cells in G0/G1 phase, and S phase cells decreased significantly (P < 0.05). The expression of cyclin D1, cyclin A, cyclin E and CDK2/4/6 were significantly down-regulated (P < 0.05), the expression of P53 and P21 was significantly upregulated after treating for 24 h with HNK (P < 0.05). After 24 h treatment with HNK, HL-60 cell apoptosis increased significantly with the upregulation of activated caspase-3, -9, BAX expression and the downregulation of BCL-2, BCL-XL expression. The MAPK subfamily, P38 and JNK were not significantly changed, but the expression of MEK1/2-ERK1/2 was significantly downregulated (P < 0.05). It is concluded that HNK arrestes the cells at G0/G1 phase and induces HL-60 cell apoptosis through the intervention of MEK1/2-ERK1/2 signaling pathway.
Subject(s)
Apoptosis/drug effects , Biphenyl Compounds/pharmacology , Cell Proliferation/drug effects , Lignans/pharmacology , Caspase 3 , Cell Cycle , Cyclin D1 , Cyclin E , Cyclin-Dependent Kinase 2 , HL-60 Cells , Humans , Oncogene Proteins , Signal Transduction , bcl-2-Associated X ProteinABSTRACT
This study was aimed to explore the effect of arsenic trioxide combined with curcumin on proliferation and apoptosis of KG1a cells and its potential mechanism. The cell survival rate was mesured by MTT; colony formation capacity was examined by methylcellulose colony formation test; flow cytometry was used to analyse the cell surface molecules, cell apoptosis rate and cell cycle; the cell morphology was observed with Wright-Giemsa staining and the protein expression of BCL-2, BAX, PARP was detected by Western blot. The results showed that the phenotype of KG1a cells was CD34(+)CD38(-), while the phenotype of HL-60 cell was CD34(+)CD38(+). The former possessed a stronger colony ability than the latter. Effect of curcumin and arsenic trioxide alone on cell proliferation and inhibition was in dose-dependent manner. Compared with single drug-treatment group, the cell survival rate and colony number were lower, and the apoptosis rate was higher in combined drug-treatment group. Protein expression of BCL-2 and PARP was upregulated, while the protein expression of PARP was downregulated in the combined treatment group. It is concluded that compared with HL-60 cells, KG1a cells are the earlier leukemia stem/progenitor cells. Arsenic trioxide combined with curcumin can effectively inhibit the KG1a cell proliferation and induce apoptosis, which may be associated with the downregulation of BCL-2 and PARP protein expression and the upregulation of BAX protein expression.
